Analysis shows increased healthcare utilisation and costs for older patients on kidney replacement therapy near end-of-life, indicating significant impacts on healthcare resources.
In the last year of life, healthcare utilisation is higher for patients on KRT compared to controls, with a further increase towards end-of-life, along with higher KRT-unrelated costs.
No takes yet. Share an insight, caveat, or question.
Jongejan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: